This section is password-protected. Please use the group password to access the documents.
EORTC opens trial for patients with high grade undifferentiated uterine sarcoma, a rare cancer 16/02/2015
Maintenance erlotinib after first-line treatment in ovarian cancer does not improve progression-free survival versus obs 01/06/2012
Delaying chemotherapy can benefit women with relapsed ovarian cancer: Results of the EORTC 55955 trial 10/11/2010
EORTC trial 55971 compares treatment options for patients with stage IIIC or IV ovarian carcinoma 02/09/2010
Dr. Leen Verleye completes Research Fellowship at EORTC Headquarters with the EORTC Gynecological Cancer Group 01/09/2010